In the study of Kilpinen and his team in 2008, the FMNL1 mRNA expression profile was obtained in both healthy and tumor samples of 18 different tissue types, and its expression was observed, albeit slightly, in both healthy and tumor tissues of the prostate [20]. Here, FMNL1 is linked to neoplasm.